Theme: Shaping the Future of Cancer care
World Oncologists 2018
World Oncologists 2018 invites participants, moderators, representatives and exhibitors and so on from across the globe to Chicago, USA.
Market Analysis Report:
Cancer is a disease, in which cells undergo mutation and starts to divide uncontrollably and destroy body tissue. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation and/or surgery. Metastases are the major cause of death from cancer. Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012.
Cancer is a complex medical condition that requires a multidisciplinary approach regarding its treatment. This approach is sweeping and ranges from well-being advancement to counteractive action and screening, diagnosis, treatment, restoration and palliative care.
“Cancer Diagnostics” Market by Methods (Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy) for Blood Cancer, Breast Cancer, Colorectal Cancer (CRC), Lung Cancer, Others: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, global demand for cancer diagnostics was valued at USD 80.67 billion in 2014, and is expected to reach USD 128.6 billion in 2020, growing at a CAGR of 7.6% between 2015 and 2020.
Market Value of Cancer Therapies
The global market for cancer therapies was worth $110.6 billion in 2013 and this should increase to over $175.6 billion by 2018, a compound annual growth rate (CAGR) of 12.6%. Although significant improvements in the diagnosis and development of various compounds to treat cancer have been made, cancer remains a major healthcare challenge worldwide.
Market Growth of Cancer drugs
Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies because of the high unmet need for improved treatments for multiple types of cancer. The global cancer market in 2010 was valued at $54 bn, an increase of 5.1% over the previous year’s sales of $51.3 bn and is forecasted to grow at a CAGR of 6.9% from 2010-16; reaching $81 bn in 2016. GMR Data forecast that the global cancer drugs and treatments market will reach $143.7 bn by 2025.
Organizations Supporting Cancer Research in USA
- American Association for Cancer Research
- American Society of Clinical Oncology
- Brain Tumor Society
- Cancer Prevention Institute of California
- Dana–Farber Cancer Institute
- Foundation for Advancement in Cancer Therapy
- Gynecologic Oncology Group
- Head and Neck Cancer Alliance
- Inflammatory Breast Cancer Association
- Karmanos Cancer Institute
- Ludwig Cancer Research
- Markey Cancer Center
- National Cancer Registrars Association
- Northern California Cancer Center
- Oncology Drug Advisory Committee
- Pediatric Oncology Group
- Roswell Park Cancer Institute
- Seattle Cancer Care Alliance
- University of Pittsburgh Cancer Institute
- University of Pittsburgh Cancer Institute
- Walker Cancer Research Institute
Universities working on Cancer Research
- The Institute of Cancer Research, London
- Massachusetts Institute of Technology
- Cancer Research UK Cambridge Institute
- Oxford Institute for Radiation Oncology
- University of Glasgow
- UCL Cancer Institute
- Cancer Research UK Edinburgh Centre
- Cancer Research Network - The University of Sydney
- University of Chicago Medicine Comprehensive Cancer Center
- University of Arizona Cancer Center
- Cancer Research UK Centre - University of Southampton
- Cancer - Research - Cardiff University
- Sheffield Cancer Research - The University of Sheffield
- Queen's Cancer Research Institute - Queen's University
15th World Oncologists Annual Conference International Conferences invites all the participants from all over the world to attend the prestigious Scientific Conference on Cancer and its advances and Radiation Medicine during December 7-8, 2018 in Chicago, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.
Track 1: Cancer
The genetic changes that contribute to cancer tend to affect three main types of genes - proto oncogenes, tumor suppressor genes, and DNA repair genes. These changes are sometimes called “drivers” of cancer. Proto-oncogenes are involved in normal cell growth and division. However, when these genes are altered in certain ways or are more active than normal, they may become cancer-causing genes (or oncogenes) allowing cells to grow and survive when they should not. Tumor suppressor genes are also involved in controlling cell growth and division. Cells with certain alterations in tumor suppressor genes may divide in an uncontrolled manner. DNA repair genes are involved in fixing damaged DNA. Cells with mutations in these genes tend to develop additional mutations in other genes. Together, these mutations may cause the cells to become cancerous. The process by which cancer cells spread to other parts of the body is called metastasis. Metastatic cancer spreads from the part of the body where it originated (the primary site) to other parts of the body. A risk factor is anything that increases a person’s chances of developing a Tumor. Although factors often influence the development of a tumor, most do not directly cause it. Some people with several risk factors never develop a tumor, while others with no known risk factors do. Some risk factors are as Age, Gender, Race/Ethnicity, Family history, Immune system suppression, arsenic exposure. Generally, the cause of Cancer is unknown. People who have one of the rare family syndromes have a higher risk of developing Tumors.
Track 2: Cancer Staging
Cancer staging is the process of determining how much the cancer has spread out inside the body and where it is located. Staging describes the severity of an individual's cancer based on the magnitude of the original (primary) tumor as well as on the extent the cancer has spread in the body. Understanding the stage of the cancer helps doctors to develop a prognosis and design a treatment plan for individual patients.
· Clinical Staging
· Pathologic Staging
· Post-Therapy or Post-Neoadjuvant Therapy Staging
Track 3: Types of Cancer
The phenomenon of Cancer cells spreading to other parts of the body is called metastasis. Metastatic cancer has spread from the part of the body where it started (the primary site) to other parts of the body. There are a number of different types of Cancer. They are generally are called after the organ or type of cell they develop in the beginning, Medical Illustrations, Risk Factors, Prevention, Symptoms & Signs, Diagnosis, Stages, Treatment Options, About Clinical Trials, Latest Research, Coping with Treatment, Follow-Up Care, Survivorship, The American Society of Clinical Oncology (ASCO) believes that all treatment decisions should be made between patients and their doctors. Tumor most often develops in the gut or pancreas. These tumors are sometimes grouped together and called gastroenteropancreatic neuroendocrine tumors or GEP NETs in short. NETs of the gut are most often carcinoid tumors. They may also just be called carcinoid. NETs that develop in the pancreas are also called endocrine tumors of the pancreas. Some of these tumors can also develop outside the pancreas. For example, gastrinomas have been reported in the medical literature to develop in the ovaries, kidneys, stomach and liver, and not just in the pancreas and small bowel area. Common types of Cancer which are diagnosed most often are Breast Cancer, Bladder Cancer, Colorectal Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Melanoma, Oral and Oropharyngeal Cancer, Pancreatic, Prostate, Thyroid Cancer, Uterine Cancer.
Track 4: Gastrointestinal Cancers
Gastro-Intestinal (GI) Cancer is a term for the group of cancers that affect the digestive system. The known risk factors for gastrointestinal cancers currently include smoking, alcohol consumption and obesity, asbestos etc. This includes cancers of the Esophagus, Gall bladder, Liver, Pancreas, Stomach, Small intestine, Bowel (large intestine or Colon and Rectum), and Anus
· Esophageal Cancer (Carcinoma)
· Gastric Cancer
· Hepatocellular Carcinoma
· Pancreatic Cancer
Track 5: Hematologic Cancers
Hematologic cancers affect he production and function of ones’ blood cells. Most of these cancers originate in the bone marrow where blood is produced. Stem cells in the bone marrow mature and develop into three types of blood cells: red blood cells, white blood cells, or platelets. In most blood cancers, the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells, or cancerous cells, prevent the blood from performing many of its functions, like fighting off infections or preventing serious bleeding.
Track 6: Head and neck cancers
Head and Neck cancers usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). These squamous cell cancers are often referred to as squamous cell carcinomas of the head and neck. Head and neck cancers can also develop in the salivary glands, but salivary gland cancers are relatively uncommon. Salivary glands contain different types of cells that can become cancerous, so there are many different types of salivary gland cancer. Cancers of the head and neck are further categorized by the area of the head or neck in which they begin from Oral cavity, Pharynx, Larynx, Para-nasal sinuses and Nasal cavity, Salivary glands.
Track 7: Neuro-oncology
Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, giloblastoma, multiforme, ependymoma, pontneglioma, and brain stem tumors are among the many examples of these). Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma are among the worst. In these cases, if untreated life span usually amounts to only a few months, and survival with current radiation and chemotherapy treatments may extend that time from around a year to a year and a half, possibly two or more, depending on the patient's condition, immune function, treatments used.
Track 8: Radiation Oncology
Radiation Medicine is a process in which they use high-energy radiation, in the form of waves or particles, to destroy cancer cells by damaging their DNA. Because radiation can harm healthy cells, treatment must be carefully planned and precisely conducted to minimize side effects. Radiation therapy may be given before, during, or after other therapies in your treatment plan. It may be used alone or with other treatments to destroy cancer cells, shrink tumors, prevent recurrence and relieve symptoms caused by the cancer, such as pain. The Radiation team plans the treatment by choosing the type, dose and area where the radiation therapy is to be performed. Internal radiation (these include different radioactive materials like seeds, beads, wires or other radioactive substances for the treatment by placing them within the body near the cancer cells. People involved in radiation medicine are Medical Physicist, Radiation Oncologist, Dosimetrist, Radiation Therapist .
Track 9: Endocrine and Neuroendocrine Tumors
An endocrine tumor is a growth that affects the parts of the body that secrete hormones. Because an endocrine tumor arises from cells that produce hormones, the tumor itself can produce hormones. These hormones are produced in excessive amounts by endocrine tumors and then released into the blood. The excessive amounts of hormones in the blood produce marked abnormal effects on the body. A neuroendocrine tumor begins in the area showing combination of hormone-producing endocrine cells and nerve cells. Neuroendocrine cells are found throughout the body in organs such as the lungs and gastrointestinal tract, including the stomach and intestines. Neuroendocrine cells perform specific functions, such as regulating air and blood flow through the lungs and controlling how quickly food moves through the gastrointestinal tract. They are other types of tumors in endocrine and neuroendocrine tumors.
· Pancreatic Cancer
· Thyroid Cancer
· Carcinoid Tumor
· Merkel Cell Cancer
· Neuroendocrine Carcinoma
Track 10: Breast Cancer
Breast cancer can begin in different areas of the breast; the ducts, the lobules, or in some cases, the tissue in between. In this section, we could include the different types of breast cancer, including non-invasive, invasive, recurrent, and metastatic breast cancers. Breast cancer is a phenomena that can even occur in men. Breast tissue contains fat and connective tissue, lymph nodesand blood vessels, they are made up of glands called tubules that can produce milk and thin tubes called ducts that carry the milk to the nipple. The most common type of breast Cancer is ductal Carcinoma. Breast Cancer can also begin in the cells of the lobules in other tissues in the breast.
Track 11: Reproductive Cancer
Reproductive Cancers are those Cancers that occur in the reproductive organs of both Women and Men. In Women, these are Cancers that commonly occur in the breast, cervix, vulva, endometrium or Ovaries. In men reproductive Cancer can be found in the prostate, testicles, and penis.
Track 12: Surgical Oncology
Surgery is the main treatment in nearly every case of cancer, and it is the main treatment for both pheochromocytoma and Merkel cell cancer. During surgery, the doctor removes the tumor along with a small border of healthy tissue around the tumor, called a margin For pheochromocytoma, laparoscopic surgery may be performed. Laparoscopic surgery is a less invasive type of surgery that uses three or four small incisions instead of one large incision. A thin, lighted tube called a laparoscope that is attached to a video camera is inserted through one opening to guide the surgeon. Surgical instruments are inserted through the other openings to perform the surgery. If removing the tumor using surgery is not possible, it is called an inoperable tumor, and the doctor will recommend another type of treatment. The patient candidate forsurgery does not depend on factors such as the type, size, location, grade and stage of the Tumor along with the consideration of the general health factors like age, physical fitness and other coexisting medical conditions. Surgery will be combined with other Cancer treatments, such as chemotherapy, Radiation therapy or hormone therapy in some Cases.
Track 13: Immuno Oncology
The immune system’s natural capacity to detect and destroy abnormal cells may prevent the development of many cancers. However, cancer cells are sometimes able to avoid detection and destruction by the immune system. The latest exciting research breakthrough for cancer treatment is immune-oncology. This type of treatment enhances the patient’s own immune system to stop the growing cancer cells. This treatment is with the T-cells. These T-cells usually recognize cancer cells as being foreign and attack those cells. In this treatment the drugs will suppress the PD-L1 molecule that is available on the surface of the cancer cell and that will allow the T-cell to attack that cancer cells. The current research is mainly going on the Immuno-Oncology way with good growth rate and treatment success.
Track 14: Cancer Biomarkers
Biomarkers have a greater role in the study of cancer, which involves the risk assessment, screening, diagnosis, prognosis, prediction of the treatment response, and monitoring of the progression of the disease. As the biomarkers play an important role in every condition of the disease, the biomarkers is evaluated accurately, including Analytical validation, Clinical validation and Clinical utility assessment, incorporating routine clinical care. Cancer Biomarkers are also useful in the process of developing drug targets that makes it easy to deliver the drugs.
· Pharmacodynamics cancer biomarkers
· Biomarkers in cancer research and medicine
· Cancer epidemiology and biomarkers
· Immuno oncology biomarkers
· Biomarkers for the prognosis of cancer and prediction of treatment
· Use of biomarkers for developing drug targets
Track 15: Nuclear Medicine
Nuclear medicine imaging uses small amounts of radioactive materials called radiotracers that are typically injected into the blood stream, inhaled or swallowed. The radiotracer travels through the area being examined and gives off energy in the form of gamma rays which are detected by a special camera and a computer to create images of the inside of your body. Nuclear medicine imaging provides unique information that often cannot be obtained using other imaging procedures and offers the potential to identify disease in its earliest stages.
Track 16: Cancer Trends and Opportunities
Doctors and scientists are always looking for better ways to treat patients with tumor. To make scientific advances, doctors create research studies involving volunteers, called clinical trials. Many clinical trials are focused on new treatments, evaluating whether a new treatment is safe, effective, and possibly better than the current (standard) treatment. These types of studies evaluate new drugs, different combinations of existing treatments, new approaches in radiation therapy or surgery, and new methods of treatment. Patients who participate in clinical trials are often among the first to receive new treatments before they are widely available. However, there is no guarantee that the new treatment will be safe, effective, or better than a standard treatment. There are also clinical trials that study new ways to ease symptoms and side effects during treatment and managing the late effects that may occur after treatment.
World’s Oncologists conference invites Oncologists, Professors, Directors, Students and Industrial professionals from USA, Europe and Asia. Explore and learn more about Conference Series Ltd: World‘s leading Event Organizer. Meet Global Oncologists, Cancer Specialists, Doctors, Scientists Researchers and Industry Professionals from UK, Europe, USA, Middle East, and Asia at World Oncologists.
15th World Oncologists Annual Conference
Date: December 7-8, 2018
Venue: Chicago, USA
World Oncologists 2018 will be organized around the theme “Shaping the Future of Cancer care”.
World Oncologists 2018 is comprised of many interactive scientific sessions on different types of Cancer disorders as well as various diagnostic and therapeutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. World Oncologists 2018 welcomes the Oncologists, Professors, Director’s, Research scholars, Student delegates and Industrial professionals from Biomedical and healthcare sectors to be a part of it in World Oncologists.
Importance & Scope
Oncology Research 2018 will be the best platform for all the oncologists, hematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.
According to market study, annual global growth in the oncology drug market is expected to be 7.5 – 10.5 percent through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes. Payers also are expected to tighten their negotiation stance with manufacturers and adopt new payment models in an effort to drive greater value from their expenditures on these drugs.
World Oncologists are organized Conference Series Ltd which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. World Oncologists 2018 will provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.
Why to attend?
World Oncologists 2018 will provide a stimulating scientific environment and a platform for the participants to share ideas and knowledge, collaborate on Oncology related problems and network with other professionals. Discussing on various imperative topics will add an insight to ponder and confer over crux of today’s scientific and technological perk up. It will be an amazing opportunity for the attendees to explore the beautiful New York City with gaining knowledge, sure to raise insights, conflate present with future and cogitate on ideas and reality in Oncology meetings. To fight against these hard to cure cancer diseases, World Oncologists 2018 has taken this initiative to explore every aspects of Oncology research.
Chicago is the third-most populous city in the United States. With over 2.7 million residents, it is the most populous city in the state of Illinois and the Midwestern United States, and the county seat of Cook County. The Chicago metropolitan area, often referred to as Chicago land, has nearly 10 million people and is the third-largest in the U.S. The city is an international hub for finance, commerce, industry, technology, telecommunications, and transportation: O'Hare International Airport is the second-busiest airport in the world when measured by aircraft traffic; the region also has the largest number of U.S. highways and rail road freight. Chicago hosted over 52 million international and domestic visitors, a new record for the city making it one of the top visited cities in the nation. Chicago's culture includes the visual arts, novels, film, theatre, especially improvisational comedy, and music, particularly jazz, blues, soul, and gospel and house music. It also has professional sports teams in each of the major professional leagues. Chicago has many nicknames, the best-known being the Windy City.
- Reproductive Cancer
- Surgical Oncology
- Radiation Oncology
- Cancer Biomarkers
- Nuclear Medicine
- Cancer Trends and Opportunities
- World Cancer Market
- Cancer Staging
- Types of Cancer
- Hematologic Cancers
- Head and neck cancers
- Endocrine and Neuroendocrine Tumors
- Breast Cancer
To share your views and research, please click here to register for the Conference.